Paraoxonase-1 (PON1) has obtained during the last years much interest in clinical and epidemiological research focusing on its protective role in vascular disease [1,2] diabetes [3-5] and end-stage renal disease [6]. The gene discussed is PON1; the disease is stage 5 chronic kidney disease.